Clinical trial

The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

NCT00579072

Study summary

ClinicalTrials.gov

The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention Questionaires Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention fMRI scan (optional) Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2006-08-01

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

QuestionairesBEHAVIORAL

fMRI scan (optional)DEVICE

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

City of Hope National Medical Centercollaborator

Fordham Universitycollaborator

Columbia Universitycollaborator

NYU Langone Healthcollaborator

Weill Medical College of Cornell Universitycollaborator

Mapped research locations

New YorkNew York, United States1 DuarteCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00579072 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.